secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2022-12-05T23:59:59+00:00
Accession:  0001171843-22-007812
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology appoints Matthew J. Hawryluk, Ph.D. to Board of Directors
-----------------------------------------------------------------------------

- Appointed as Class II director effective Nov 29, 2022; fills vacancy from J. Melville Engle's retirement.
- Currently EVP and Chief Business Officer at Gritstone bio (NASDAQ: GRTS).
- Awarded $5,000 in common stock from the Company's 2012 Stock Incentive Plan.
- Bringing experience from Foundation Medicine and Thermo Fisher Scientific; Ph.D. in cell biology and MBA.
- His term expires at the 2023 annual meeting of stockholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/0001171843-22-007812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184322007812/f8k_120222.htm
  HTML page:      https://secwatch.observer/filing/0001171843-22-007812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer